Selected Publications

Lerchenmüller C, Hilfiker-Kleiner D „Cardiology and cardiovascular research in Germany: 5 years of gender demographics” (Clinical Research Cardiology. Feb;108(2):218-220. doi: 10.1007/s00392-018-1335-y)

Vujic A*, Lerchenmüller C*, Wu TD, Guillermier C, Rabolli CP, Gonzalez E, Senyo SE, Liu X, Guerquin-Kern JL, Steinhauser ML, Lee RT, Rosenzweig A "Exercise induces new cardiomyocyte generation in the adult mammalian heart” (Nature Communications. 1659 (2018), doi:10.1038/s41467-018-04083-1) *Authors contributed equally
Press release: Harvard Gazette

Lerchenmüller C, Lerchenmueller MJ#, Sorenson O. "Long-term Analysis of Sex Differences in Prestigious Authorships in Cardiovascular Research Supported by the NIH” (Circulation. 2018;137:880–882) # Co-corresponding authors

Lerchenmüller C, Heissenberg J, Damilano F, Bezzeridis J, Krämer I, Bochaton-Piallat ML, Hirschberg K, Busch M, Katus HA, Peppel K, Rosenzweig A, Busch H, Boerries, M#, Most P “S100A6 regulates endothelial cell cycle progression by attenuating antiproliferative STAT1 signaling” (Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):1854-67) #Co-corresponding authors 

Bezzeridis V, Platt C, Lerchenmüller C, Paruchuri K, Oh NL, Xiao C, Cao Y, Mann N, Spiegelman B, Rosenzweig A “CITED4 induces physiologic hypertrophy and promotes functional recovery after ischemic injury” (JCI Insight. 2016 Jun 16;1(9). pii: e85904)

Lerchenmüller C, Rosenzweig A “Mechanisms of Exercise-Induced Cardiac Growth“
(Drug Discovery Today 2014 Jul;19(7):1003-9)

Sen A, Ren S, Lerchenmüller C, Sun J, Weiss N, Most P, Peppel K “MicroRNA-138 Regulates Hypoxia-Induced Endothelial Cell Dysfunction by Targeting S100A1” (PLOS one 2013; 8(11): e78684)

Most P*, Lerchenmüller C, Rengo G, Mahlmann A, Ritterhoff J, Rohde D, Goodman C, Busch CJ, Laube F, Heissenberg J, Pleger ST, Weiss N, Koch WJ, Katus HA, Peppel K “S100A1 Deficiency Impairs Postischemic Angiogenesis Via Compromised Proangiogenic Endothelial Cell Function and Nitric Oxide Synthase Regulation” (Circulation Research 2013 Jan 4;112(1):66-78) * Authors contributed equally

Brinks H, Rohde D, Voelkers M, Qiu G, Pleger ST, Herzog N, Rabinowitz J, Ruhparwar A, Silvestry S, Lerchenmüller C, Mather P, Eckhart A, Katus HA, Carrel T, Koch WJ, Most P “S100A1 genetically-targeted therapy reverses dysfunction of human failing cardiomyocytes” (Journal of the American College of Cardiology 2011; 58:966-973)

Kraus C, Rohde D, Weidenhammer C, Qiu G, Pleger ST, Völkers M, Börries M, Most P “S100A1 in cardiovascular health and disease: Closing the gap between basic science and clinical therapy” (Journal of Molecular and Cellular Cardiology 2009 Oct;47(4):445-55)